Clinical Trials Logo

Infection clinical trials

View clinical trials related to Infection.

Filter by:

NCT ID: NCT04618861 Completed - Covid19 Clinical Trials

Surfactant Protein D Levels in Covid-19 Infection: Case-Control Study

Start date: October 13, 2020
Phase:
Study type: Observational

This study aims to provide some insight into the variation of SD-D protein levels in patients with Covid-19 (-) pneumonia, Covid-19 (+) pneumonia, and CT negative Covid-19 infection in comparison to the normal population through a larger number of cases. Objective of the study is to determine the serum surfactant protein D (SP-D) levels in Covid-19 pneumonia infection.

NCT ID: NCT04618276 Completed - Clinical trials for Surgical Site Infection

Effect of Photodynamic Therapy on Skin Microbiome. Single Center Study (PHOMIC-II)

Start date: January 15, 2021
Phase: N/A
Study type: Interventional

The overarching aim of this research project is to prevent orthopedic implant-associated infections. This study aims to investigate if PDT has an effect on bacterial skin colonization in order to improve skin antisepsis strategies for the prevention of surgical site infections.

NCT ID: NCT04616118 Completed - Cardiac Disease Clinical Trials

Comparing Modes of Telehealth Delivery: Phone vs. Video Visits (ASSIST)

Start date: May 27, 2020
Phase: N/A
Study type: Interventional

Given the current public health crisis the use of telehealth consultation visits including phone-only and video visits has exponentially increased. This study will investigate if the conduct of telehealth phone only visits is non-inferior in terms of patient satisfaction/experience, adherence to post-visit recommendations such as medications, blood work and other medical testing, follow up care, when compared to the conduct of video delivered telehealth visits. Patients will be randomized to receive a routine care visit via phone only vs. video.

NCT ID: NCT04614883 Completed - Covid19 Clinical Trials

Analysis of Volatile Organic Compounds in Exhaled Air and in Sweat in the Context of Suspicion of COVID-19 Infection

VOC-COVID-Diag
Start date: October 21, 2020
Phase: N/A
Study type: Interventional

In the context of the actual pandemia of the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which requires a better diagnostic strategy for the management of patients. The study of volatile organic compounds (VOC) detected in exhaled air or in sweat, is an innovative research area for respiratory diseases. The analysis of VOC can be done either by the technique of the mass spectrometry which allows the identification of each VOC in the exhaled air or by the technique of electronic nose, simpler and faster, which provides an idea of the general profile of the VOC without identifying them. The VOC have shown their interest in some situations, such as diagnostic or prognostic tool in patients followed for thoracic tumorous pathology or bronchial or pulmonary vascular diseases. Moreover, it has recently been shown that properly trained dogs would be able to detect an olfactory signature of SARS-CoV-2 infection with a specificity greater than 90%; this olfactory signature corresponds to VOCs detectable by the flair of dogs (Nosaïs-Covid19 study). Validation of the diagnostic value of VOC analyzes by non-invasive and rapid methods (electronic nose analysis or mass spectrometry; detection by the scent of dogs) for the rapid detection and early diagnosis of a SARS-CoV-2 infection warrants the performance of this clinical study.

NCT ID: NCT04611061 Completed - Influenza Clinical Trials

Kagocel® for the Prevention of ARVI and Influenza in Adults Health Care Workers

Start date: October 2, 2017
Phase:
Study type: Observational [Patient Registry]

this study evaluates the use of Kagocel for the prevention of acute respiratory viral infections (ARVI) and influenza during the epidemic rise in morbidity in Russia in the 2017-2018 season (epidemiology: number of cases during the period of taking Kagocel and follow-up, severity of the disease, bacterial exacerbations, number of repeated episodes (reinfection); patients demography; safety) in health care workers who are at risk.

NCT ID: NCT04609969 Completed - Covid19 Clinical Trials

Diagnostic Performance Evaluation of a Novel SARS-CoV-2 (COVID-19) Antigen Detection Test

COVID-VIRO
Start date: October 13, 2020
Phase: N/A
Study type: Interventional

The current prospective study was designed to assess the diagnostic specificity and sensitivity of a novel antigen-based rapid detection test (COVID-VIRO®) on nasopharyngeal specimens in comparison to the reference test in a real-life setting

NCT ID: NCT04603079 Completed - Infection Clinical Trials

Nurse Leadership for Hospital Infection Control

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

The aim is to deliver an intervention to promote nurse leadership and decision-making in the hospital setting, by providing them with training for maintaining minimum service delivery standards for hospital infection control with respect to COVID-19; but also other infectious disease burden management.

NCT ID: NCT04602234 Completed - Clinical trials for Ultrasound Therapy; Complications

Diagnostic of Lower Respiratory Tract Infection by Lung Ultrasonography in General Practice

AmbuLUS
Start date: December 30, 2019
Phase: N/A
Study type: Interventional

Lower Respiratory Tract Infection (LRTI) is a frequent motive of consultation in General Practice. Cost, irradiation and availability of traditional imagery make it difficult to perform in every patient with suspected LRTI. The objective is to evaluate the performance of LUS realized by family physicians into the usual LRTI diagnostic pathway. This study is a prospective, interventional, multi-centric and open study conducted in 3 different centers by 15 General Practitioners (GP) in France. Patient complaining of dyspnea or cough were recruited from December 2019 to March 2020. GP received a training course by LUS expert before the study. The primary outcome measure was diagnosis modification after LUS. Secondary measures were therapeutic modification after LUS, decision of imagery prescription after LUS, decision of hospitalization or not after LUS, medical evolution and result of imagery initially prescribed by GP.

NCT ID: NCT04601597 Completed - Infection Clinical Trials

A Multicentre Pilot Study of Midline Catheter's Tip at a Different Position in Antimicrobial Therapy

Start date: August 12, 2020
Phase: N/A
Study type: Interventional

The research protocol was based on assigning patients to three different catheter tip groups and then observing the relationship between the tip and catheter-related complications when infusing antimicrobial agents.

NCT ID: NCT04601012 Completed - Covid19 Clinical Trials

OCTA Study: Retinal Vascular Changes in Patients With SARS-CoV-2 Infection

Start date: September 20, 2020
Phase:
Study type: Observational

This study evaluates the retinal vascular features using optical coherence tomography angiography in patients that have been affected by COVID-19.